A recent study found that combined tocilizumab and glucocorticoid therapy for at least 6 months did not fully eliminate ...

Chimeric antigen receptor-T (CAR-T) cell therapy, initially successful in hematologic malignancies, presents a promising avenue for treating solid tumors, including CRC. This review explores the ...

Amneal Pharmaceuticals has received approval from the Food and Drug Administration for a dementia treatment and a drug targeting certain types of brain tumors, as well as tentative approval for a drug ...

Cecile Richards, a prominent advocate for women's rights and other progressive causes and former President of Planned ...

The Allen Brain Cell Atlas (ABC Atlas) aims to empower researchers worldwide to explore and analyze multiple whole-brain datasets simultaneously. As the Allen Institute and its collaborators continue ...

Giant will be just one of the stars the hopefuls will be going up against, with his dominating statue making him an intimidating force. Making his debut in the Gladiators arena in season 1 ...

The researchers describe how they used sEVs, which are engineered in the lab from human cells, to target a cell-surface receptor called DR5 (death receptor 5) that many tumor cells have.

This important study presents genome-wide high-resolution chromatin-based 3D genomic interaction maps for over 50 diverse human cell types and integrates these data with pediatric obesity GWAS. The ...

Vancouver, BC, January 15, 2025--(T-Net)--AbCellera (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with AbbVie Inc. (NYSE: ABBV) to include the discovery of T-cell ...

The Spiking Neural Processor T1 is an AI chip that's modeled on the way the brain detects patterns and could extend the battery life in smart devices. When you purchase through links on our site ...